An intraosseous myoepithelial carcinoma with a EWSR1 :: PBX3 fusion
Genes, Chromosomes and Cancer · 2023
DOI: 10.1002/gcc.23148 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, Chromosomes and Cancer, 2023. Verfasst von Cecilia Haglund und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Bone Neoplasms, Carcinoma, Myoepithelioma, Neoplasms, Connective and Soft Tissue. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Herein we report a case of an intraosseous myoepithelial carcinoma harboring a EWSR1::PBX3 fusion gene. The patient was a 64‐year‐old male found to have a 7 cm destructive lesion in the distal ulna with an extraosseous soft tissue component. Microscopic examination of the resected tumor showed a spindle‐cell lesion within a sclerotic stroma and intravascular tumor emboli. At higher power the tumor cells showed moderate nuclear atypia with a high mitotic count (20 per mm 2 ). Immunohistochemistry revealed diffuse EMA positivity and focal pancytokeratin (AE1/AE3) and S100 expression, consistent with myoepithelial differentiation. NGS using the Oncomine Childhood Cancer Assay (Thermo Fisher Scientific, Inc.) revealed a EWSR1‐PBX3 fusion and ABL amplification. The patient subsequently developed local recurrence as well as distant lymph node, lung and vertebral metastases; he is currently awaiting systemic treatment in the context of a clinical trial. In this report, we present a rare case of a skeletal myoepithelial tumor harboring a EWSR1::PBX3 fusion with demonstrated histological and clinical features of malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
- Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
- Department of Oncology, Linköping University Hospital, Linköping, Sweden.
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
- Musculoskeletal Tumor Service, Karolinska University Hospital, Stockholm, Sweden.
ORCID-Profile: Cecilia Haglund, Felix Haglund de Flon
Zitieren
APA
Haglund, C., Zemmler, M., Tsagkozis, P., & Haglund de Flon, F. (2023). An intraosseous myoepithelial carcinoma with a EWSR1 :: PBX3 fusion. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.23148
Vancouver
Haglund C, Zemmler M, Tsagkozis P, Haglund de Flon F. An intraosseous myoepithelial carcinoma with a EWSR1 :: PBX3 fusion. Genes, Chromosomes and Cancer. 2023. doi:10.1002/gcc.23148
BibTeX
@article{Haglund2023,
author = {Haglund, Cecilia and Zemmler, Maja and Tsagkozis, Panagiotis and Haglund de Flon, Felix},
title = {An intraosseous myoepithelial carcinoma with a EWSR1 :: PBX3 fusion},
journal = {Genes, Chromosomes and Cancer},
year = {2023},
doi = {10.1002/gcc.23148}
}
EUVIMED